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ABSTRACT
Background and Objectives: Tuberculous (TB) pericarditis is a major cause of constrictive pericarditis requiring pericar-
diectomy. We sought to determine initial prognostic factors in patients with TB pericarditis. Subjects and Methods: We 
evaluated initial presentation and clinical outcomes (mean follow-up 32±27 months) in 60 consecutive patients newly diag-
nosed with TB pericarditis. Results: Initial presentations were pericardial effusion (PE), effusive-constrictive pericarditis, 
and constrictive pericarditis in 45 (75%), 9 (15%), and 6 (10%) patients, respectively. Of the 54 patients without initial constric-
tive pericarditis, 32 (59%) showed echogenic materials in PE, including frond-like exudative coating and fibrinous strands. 
These patients had a longer disease duration before diagnosis, were initially more symptomatic, in a more advanced state, 
showed more persistent pericardial constrictions (38% vs. 0%, p<0.001) despite anti-TB medications, and tended to require 
pericardiectomy more often (19% vs. 0%, p=0.07, p<0.05 by Kaplan-Meier). All patients with effusive-constrictive pericardi-
tis showed echogenic PE. Of the 60 total patients, 10 (17%) underwent pericardiectomies during follow-up. All of these pa-
tients showed initial pericardial constrictions, whereas no patient without initial pericardial constriction underwent pericar-
diectomy (p<0.001). Seven patients showed transient pericardial constrictions that resolved without pericardiectomy. 
Conclusion: Initial pericardial constriction and echogenic PE are poor prognostic signs for persistent pericardial constric-
tion and pericardiectomy in patients with newly diagnosed TB pericarditis. These results suggest that early diagnosis and 
prompt anti-TB medication may be critical. (Korean Circ J 2010;40:377-386)
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tures, including pericardial effusion (PE), effusive-constricti-
ve pericarditis, and constrictive pericarditis.
2)3) Pericardial con-
strictive scarring, the most serious complication requiring 
pericardiectomy, occurs in 18-46% of patients with TB PE de-
spite anti-TB chemotherapy and treatment with corticoste-
roids.
3-5) The predictors of TB constrictive pericarditis have 
been suggested in several small studies,
6-12) but remain to be 
clearly established.
3) Echogenic materials seen in PE on 2-di-
mensional echocardiography, such as exudative coating and 
fibrinous strands, can predict pericardial complications irre-
spective of underlying disease etiologies,
13) and are more spe-
cific to TB PE.
14-18) However, the clinical prognostic value of 
such echogenic materials in TB PE has not been clearly dem-
onstrated. Therefore, we evaluated clinical outcomes of new-
ly-diagnosed TB pericarditis patients and determined initial 
prognostic predictors for the development of constrictive 
pericarditis requiring pericardiectomy.
Introduction
Tuberculosis (TB) continues to be a leading cause of mor-
bidity and mortality from infectious disease worldwide,
1) 
and TB pericarditis is arguably the leading cause of pericardi-
tis in the world, despite a low incidence in developed coun-
tries. TB pericarditis patients initially present with diverse fea-378   Echocardiography in Tuberculous Pericarditis
Subjects and Methods
From 1995 to 2007, 60 consecutive patients (mean age 58± 
19 years, 30 females) were newly diagnosed with TB pericardi-
tis at the Asan Medical Center, Seoul, Korea, and treated with 
anti-TB chemotherapy. Sixteen patients were also included 
in our previous report.
13) No patient had any evidence of hu-
man immunodeficiency virus infection. For each patient, a 
complete clinical history was taken, and physical examina-
tion, chest X-ray, and 2-dimensional Doppler echocardiogra-
phy were performed. Symptom onset time could be identified 
in 54 patients. Of the 60 patients, 47 underwent pericardio-
centesis and/or pericardiostomy. Pericardial fluid and biopsy 
specimens were analyzed for chemistry, cytology, histopathol-
ogy examination, acid-fast bacilli staining, culture for Myco-
bacterium tuberculosis, adenosine deaminase (ADA) mea-
surement, and polymerase chain reaction (PCR) detecting M. 
tuberculosis.
19) Diagnosis of TB pericarditis was categorized as 
definite or probable, as previously reported.
3)4) A “definite” di-
agnosis was made when M. tuberculosis was found in PE fluid 
or pericardial samples by acid-fast bacilli staining, TB culture, 
or positive TB-PCR; or when granuloma was seen. All bacte-
riologically confirmed cases were pan-susceptible to anti-TB 
drugs. A “probable” diagnosis was made when there was 
proof of TB elsewhere in a patient with unexplained pericar-
ditis or when PE showed a lymphocyte-dominant exudate 
with a high ADA (>40 U/L) level.
All patients underwent transthoracic 2-dimensional echo-
cardiography (Sonos 7500, Philips Medical Systems, Andover, 
MA; Vivid 7, General Electric, Waukesha, WI; Acuson Sequo-
ia, Mountain View, CA, USA), and all data were analyzed by a 
single expert. Patients with PE were divided into two groups 
by differences in initial echocardiographic characteristics of 
PE and pericardium. Echo-free PE was defined as PE with-
out any echogenic materials (Fig. 1A),
20) whereas echogenic 
PE was defined as PE showing echogenic materials in PE or 
on the pericardium (Fig. 1B).
15)17)20) 
Effusive-constrictive pericarditis was diagnosed when con-
strictive physiology was not resolved by PE removal, or when 
constrictive physiology was observed together with only a mild 
to moderate amount of PE. Constrictive physiology was defin-
ed as a significant respiratory variation in mitral inflow E wave 
velocity (≥25%) and a prominent increase in diastolic flow re-
versal with expiration in the hepatic vein on 2-dimensional Dop-
pler echocardiography.
21)22) Chest contrast-enhanced comput-
ed tomography (CT) was performed in 39 patients.
Clinical and echocardiographic observations were conduct-
ed for 32±27 months (median: 25 months) on patients taking 
adequate anti-TB medications for at least 6 months. Pericardial 
constriction was diagnosed when constrictive physiology (as 
described above) and diffuse pericardial thickening without 
PE were found on 2-dimensional Doppler echocardiogra-
phy.
21)23) Referral for pericardiectomy was determined by at-
tending physicians’ discretion.
Numeric variables are expressed as means±SD. Statistical 
analysis of between-groups differences was performed using 
Student’s unpaired t-test. The χ2 test and Fisher’s exact test were 
used to compare frequency ratios between groups. A Kaplan-
Meier analysis and the log rank test were employed to compa-
re event-free survival rates. A p of <0.05 was considered signifi-
cant.
Results
Initial presentations were PE, effusive-constrictive pericar-
ditis, and constrictive pericarditis in 45 (75%), 9 (15%), and 6 
(10%) patients, respectively. Of the 45 patients who present-
ed with PE, 9 patients (15%) showed initial cardiac tampon-
ade defined as a large amount of PE, significant respiratory 
variations in mitral inflow E velocity, and diastolic collapse of 
the right atrium or ventricle. Of the 9 patients with effusive-
constrictive pericarditis, constrictive physiology was not re-
solved by PE removal in 4 patients and constrictive physiolo-
gy was observed together with only mild to moderate PE in 5 
patients. Of the 54 patients without initial constrictive peri-
carditis, 32 (59%) showed echogenic PE, whereas 22 showed 
echo-free PE. Clinical features of both groups are summariz-
ed in Table 1. Weight loss was more prevalent in patients with 
echogenic PE than in those with echo-free PE, and the form-
er patients presented with a greater number of symptoms, of 
longer duration, than did the latter cohort. All nine patients 
with effusive-constrictive pericarditis showed echogenic PE.
Pleural effusion on initial chest X-ray and pericardial thick-
Fig. 1. Representative examples of echo-free pericardial effusion 
(PE) (A) and echogenic PE (B). PE: pericardial effusion.
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Table 1. Comparison of clinical characteristics of echo-free and echogenic pericardial effusion patients
Echo-free (n=22) Echogenic (n=32) p
Age (years) 53±23 61±170 0.206
Male/Female 14/8 14/180 0.176
Weight (kg) 59.7±11.1 54.4±9.300 0.063
Height (cm) 165.5±10.3 159.1±9.6000 0.053
Symptom
Number of symptoms
Symptom duration (days)
Dyspnea (%)
Cough (%)
Fever (%)
Chest pain(%)
Fatigue (%)
Edema (%)
Weight loss (%)
Abdominal pain (%)
Sweat (%)
2.9±1.1
17±22
15 (68.2)0
10 (45.5)0
9 (40.9)
9 (40.9)
4 (18.2)
5 (22.7)
3 (13.6)
5 (22.7)
3 (13.6)
4.0±1.50
40±380
27 (84.4)
19 (59.4)
20 (62.5)
09 (28.1)
14 (43.8)
13 (40.6)
15 (46.9)
08 (25.0)
04 (12.5)
0.003
0.011
0.194
0.407
0.167
0.386
0.078
0.242
0.018
1.000
1.000
Manifestation (%)
Pericardial effusion
Effusive-constrictive
22 (100)0.
0 (0)00.
23 (71.8)
09 (28.1)
0.016
ECG (%)
Nonspecific ST-T change
Low voltage
Sinus tachycardia
Atrial fibrillation
Normal
12 (54.5)0
12 (54.5)0
5 (22.7)
4 (18.2)
3 (13.6)
15 (46.9)
17 (53.1)
12 (37.5)
05 (15.6)
04 (12.5)
0.782
1.000
0.372
1.000
1.000
Initial laboratory data
WBC (/mm
3)
ESR (mm/h)
CRP (mg/dL)
7186±1960
50±33
6.17±4.36
7440±49040
61±340
8.97±6.590
0.131
0.328
0.098
Chest X-ray (%)
Cardiomegaly
Pulmonary edema
Pleural effusion
Pulmonary TB lesion
22 (100).0
1 (4.5)0
8 (36.4)
3 (13.6)
29 (90.6)
2 (9.4)
29 (90.6)
07 (21.9)
0.262
0.638
<0.001
0.501
Chest CT (%)
Pericardial calcification
Pericardial thickening
Lymphadenopathy
Lung field lesion
0n=14
2 (14.3)
1 (7.1)0
7 (50.0)
8 (57.1)
n=20
.00 (0)0.0.
18 (90.0)
13 (65.0)
12 (60.0)
0.162
<0.001   
0.487
1.000
Other Tb site  (%)
Pulmonary
Other
5 (22.7)
1 (4.5)0
11 (34.4)
1 (3.1)
0.774
Pericardial fluid analysis
Bloody (%)
Lymphocyte-dominant (%)
Protein (g/dL)
LDH (U/L)
Adenosine deaminase (U/L)
WBC (/mm
3)
0n=19
6 (35.3)
17 (89.5)0
5.1±0.7
1390±1456
58±27
2868±2674
n=23
10 (43.5)
21 (91.3)
5.3±0.60
1882±13300
104±6500
7780±14425
0.747
1.000
0.240
0.271
0.004
0.131
ECG: electrocardiogram, WBC: white blood cell, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, TB: tuberculosis, LDH: lac-
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ening on chest CT were significantly more prevalent in pa-
tients with echogenic PE than in those with echo-free PE. 
ADA activity in pericardial fluid was higher in the former pa-
tients than in the latter group. Definite diagnoses were more 
often possible in patients with echogenic PE than in those 
with echo-free PE (Table 2), and TB-specific pericardial patho-
logy results, such as stained acid-fast bacilli and granuloma, 
were more frequently positive in echogenic patients. TB-PCR 
on PE fluid was more often positive in echogenic PE patients 
than in echo-free PE patients. Durations of anti-TB chemothe-
rapy and proportions of patients treated with adjunctive cor-
ticosteroids did not differ between the two groups (Table 3).
During follow-up, new pericardial constrictions developed 
in 10 patients, of whom 7 had shown echogenic PE on initial 
echocardiography (Fig. 2). Of these 10 patients, 100% (3/3) of 
echo-free PE patients and 29% (2/7) of those with initial echo-
genic PE showed transient pericardial constrictions that re-
solved during longer follow-up. No patient with initial echo-
free PE but 5 patients (22%) with initial echogenic PE with-
out initial pericardial constrictions, developed unresolved 
pericardial constrictions. In nine patients with initial effusive-
constrictive pericarditis, two (22%) showed transient constric-
tions that resolved during anti-TB therapy, whereas six (67%) 
required pericardiectomies. The overall incidence of pericar-
dial constriction on both initial and follow-up echocardio-
graphic evaluations was higher in patients with initial echo-
genic PE than in those with initial echo-free PE (50.0% vs. 
13.6%, p<0.01). During follow-up, pericardiectomies were 
Table 2. Comparison of diagnostic criteria of tuberculous pericar-
ditis between echo-free and echogenic pericardial effusion patients
Echo-free Echogenic p
TB in pericardial fluid (%) 
TB culture-positive (%)
TB PCR-positive (%)
Bacilli or granuloma (%)*
TB in other sites (%)
High ADA (%)
Criterion count 
Definite diagnosis (%)
01/19 (5.3)0
02/19 (10.5)
02/17 (11.8)
04/15 (26.7)
06/22 (27.3)
14/19 (73.7)
1.32±0.560
06/22 (27.3)
0/26 (0)00
08/26 (30.8)
10/21 (47.6)
17/20 (85.0)
12/32 (37.5)
19/24 (79.2)
2.06±0.98
24/32 (75.0)
0.422
0.154
0.034
0.001
0.560
0.728
0.001
0.002
*Echo-free: TB (0), Granuloma (4); Echogenic: TB (2), Granuloma 
(15). TB: tuberculosis, PCR: polymerase chain reaction, ADA: ad-
enosine deaminase
Table 3. Treatments and clinical events in patients with echo-free 
and echogenic pericardial effusion
Echo-free
(n=22)
Echogenic
(n=32)
p
Anti-tuberculosis drugs
Medication duration (months)
Secondary drugs (%)
13±16
2 (9.1)0
10±5
3 (9.4)0
0.434
1.000
Steroids (%)
Use 
Initial dose (mg/day)
8 (36.4)
56±12
18 (56.3)0
050±11
0.176
0.271
Events (%)
Transient constriction
Persistent constriction
Pericardiectomy
3 (13.6)
0 (0)00.
0 (0)00.
4 (12.5)
12 (37.5)0
6 (18.8)
1.000
0.001
0.071
Fig. 2. Clinical outcomes of tuberculous pericarditis patients according to clinical and echocardiographic classifications. 
Tuberculous pericarditis
(n=60)
Echogenic
(n=23)
Echogenic
(n=9)
Resolved
(n=2)
Echo-free
(n=22)
Constrictive pericarditis
(n=6)
Effusive-constrictive pericarditis
(n=9)
Pericardial effusion
(n=45)
No constriction
(n=19)
No constriction
(n=16)
Constriction
(n=3)
Constriction
(n=7)
Resolved
(n=3)
Resolved
(n=2)
Medical
(n=8)
Pericardiectomy
(n=10)
Constriction
(n=5) 1 2 6 4Hyung Oh Choi, et al.   381
performed on six patients with initial echogenic PE, but in 
no patient with initial echo-free PE. Of six patients who pre-
sented with initial constrictive pericarditis, four (67%) un-
derwent pericardiectomies. None of these 6 patients showed 
pericardial constriction resolution despite the use of anti-TB 
medications. 
Of the 60 patients, 18 (30%) showed persistent constrictive 
pericarditis during follow-up. The incidence of unresolved 
pericardial constriction was higher in patients with initial con-
strictions than in those without, and was greater in patients 
with echogenic PE than in those with echo-free PE, as shown 
by Kaplan-Meier analyses of the unresolved constrictive peri-
carditis development rate (Fig. 3). Unresolved constrictive pe-
ricarditis developed in about 38% of patients who presented 
with echogenic PE, and in no patient with initial echo-free 
PE. Of 18 patients with persistent constrictive pericarditis, 8 
patients were followed-up medically because their symptoms 
were tolerable with medications, including diuretics.
Of 60 patients, 10 (17%) underwent pericardiectomies dur-
ing follow-up. On initial echocardiography, these patients 
showed a higher prevalence of pericardial constriction, thick-
ening, and calcification, than did patients who did not requi-
re pericardiectomy (Table 4). The former patients showed a 
higher prevalence of pleural effusion and pericardial thick-
ening by chest X-ray and CT, and had longer symptom dura-
tion, than did patients who did not require pericardiectomy. 
The durations of anti-TB medication and proportions of pa-
tients treated with steroids did not differ significantly between 
the two groups. Patients with pericardial constrictions on ini-
tial echocardiography showed a higher pericardiectomy rate 
than did those without constriction, by Kaplan-Meier analy-
sis (p<0.001) (Fig. 4A). Similarly, patients with initial echoge-
nic PE showed a higher pericardiectomy rate than did those 
with echo-free PE (p<0.05) (Fig. 4B). No mortality from peri-
carditis or surgery was observed in our study population. For 
38 patients with initial constrictive physiology or echogenic 
PE (Table 5), Kaplan Meier analysis revealed that rate of per-
sistent constriction during follow-up was lower in patients 
with than without steroid therapy (p=0.011) (Fig. 5).
Discussion
Predictors of constrictive pericarditis and 
pericardiectomy
Echogenic substances in PE are suggestive of TB pericardi-
tis and signs of pericardial inflammation and a hypersensi-
tivity reaction.
14-17) However, echogenic substances are also 
found in the PE of other etiologies as risk factors for the de-
velopment of constrictive pericarditis, irrespective of cause, 
in patients with PE.
13)24)25) We previously reported on 178 con-
secutive patients with moderate to severe PE of any etiology, 
including 16 patients with TB PE.
13) This study of 60 patients 
diagnosed with TB pericarditis was designed to evaluate the 
clinical outcome of TB pericarditis, and identify poor prog-
nostic indicators for permanent constriction and pericardi-
ectomy. Initial constrictive physiology was the major poor 
prognostic factor in TB pericarditis, which we did not find in 
our previous study as we only included PE patients. In this 
study, 59% of patients with TB pericarditis accompanied by 
PE showed echogenic PE, consistent with previous reports.
15)17) 
In PE patients, intrapericardial echogenic materials were as-
sociated with a greater level of symptomatic presentation and 
a more advanced disease state. All patients who presented with 
effusive-constrictive pericarditis showed echogenic PE. Pa-
tients with initial echogenic PE developed more unresolved 
pericardial constrictions and required pericardiectomy despite 
the use of anti-TB medications, than did those with echo-free 
PE. In previous studies, echogenic PE was regarded as specific 
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Fig. 3. Kaplan-Meier analyses of developing persistent constrictive pericarditis in patients with or without initial pericardial constriction (A), and 
in patients with echogenic pericardial effusion (PE) or echo-free PE (B). PE: pericardial effusion.382   Echocardiography in Tuberculous Pericarditis
Table 4. Comparison of initial clinical and echocardiographic characteristics between patients who required pericardiectomies and those 
who did not
Pericardiectomy (+) (n=10) Pericardiectomy (-) (n=50) p
Age (years) 50±13 59±12 0.177
Male/Female 4/6 26/24 0.731
Weight (kg) 55.7±10.4 56.1±10.4 0.900
Height (cm) 161.2±10.80 161.0±10.20 0.901
Symptom
Number of symptoms
Symptom duration (days)
Dyspnea (%)
Cough (%)
Fever (%)
Chest pain (%)
Fatigue (%)
Edema (%)
Weight loss (%)
Abdominal pain (%)
Sweating (%)
4.2±1.2
105±280
9 (90.0)
7 (70.0)
6 (60.0)
3 (30.0)
3 (30.0)
4 (40.0)
4 (40.0)
3 (30.0)
3 (30.0)
3.5±1.5
24±23
38 (76.0)
28 (56.0)
27 (54.0)
18 (36.0)
18 (36.0)
16 (32.0)
15 (30.0)
12 (24.0)
05 (10.0)
0.191
<0.001
0.436
0.499
0.718
0.711
0.700
0.120
Manifestation (%)
Pericardial effusion
Effusive-constrictive
Constrictive pericarditis
0 (0)00.
6 (60.0)
4 (40.0)
45 (90.0)
3 (6.0)
2 (4.0)
<0.001
Initial laboratory data
WBC (/mm
3)
ESR (mm/h)
CRP (mg/dL)
6360±2491
57±53
4.61±4.93
7422±4081
55±34
7.95±5.96
0.432
0.919
0.168
Chest X-ray (%)
Cardiomegaly
Pulmonary edema
Pleural effusion
Pulmonary TB lesion
5 (50.0)
0 (0)00.
10 (100)0.
2 (20.0)
48 (96.0)
06 (12.0)
33 (66.0)
10 (20.0)
0.001
0.577
0.049
1000.
Chest CT (%)
Pericardial calcification
Pericardial thickening
Lymphadenopathy
Lung field lesion
n=8
1 (12.5)
8 (100)
4 (50.0)
4 (50.0)
0n=31
2 (6.5)
16 (51.6)
17 (54.8)
18 (58.1)
0.505
0.015
1000.
0.709
Diagnostic criteria (%)
TB in pericardial fluid
TB culture-positive
TB PCR-positive
Bacilli or granuloma
TB in other sites
High ADA
Criteria count
Definite diagnosis
1 (33.3)
0 (0)00.
3 (60.0)
8 (80.0)
6 (60.0)
0 (0)00.
1.80±0.79
9 (90.0)
1 (2.3)
10 (23.3)
10 (28.6)
15 (51.7)
17 (34.0)
33 (78.6)
1.72±0.93
24 (48.0)
0.128
1000.
0.307
0.152
0.161
0.058
0.800
0.017
Echogenic PE (%) 100 (6/6)000     54.2 (26/48)00 0.071
Anti-tuberculosis drugs
Medication duration (months)
Secondary drugs (%)
15±14
2 (20.0)
11±11
05 (10.0)
0.360
0.330Hyung Oh Choi, et al.   383
for TB PE,
14-18) but the high prevalence of echogenic PE makes 
its value in TB PE patients unclear. Here we have demonstrat-
ed that echogenic PE is a predictor of constrictive pericarditis 
in patients with TB pericarditis.
Only some patients who initially presented with effusive-
constrictive pericarditis or constrictive pericarditis required 
pericardiectomy during follow-up, whereas no patient without 
initial pericardial constriction underwent pericardiectomy. 
Some patients with pericardial thickening by initial CT need-
ed pericardiectomy. Patients who present with pericardial 
thickening and constriction and/or echogenic PE have poor 
prognoses and may develop persistent constrictive pericar-
ditis requiring pericardiectomy. TB pericarditis patients initial-
ly presenting without constriction and with echo-free PE may 
not develop permanent pericardial constriction nor require 
pericardiectomy, provided anti-TB medication is adequate.
Initial pericardial constriction and echogenic PE may reflect 
a more advanced disease state and a higher degree of pericar-
dial inflammation. Symptom duration before diagnosis was 
greater in echocardiographically advanced patients, defined as 
those showing fibrinous strands and thickened pericardia,
18) in 
agreement with our present data showing that patients with 
echogenic PE had been symptomatic for longer than echo-free 
PE patients. Patients who presented with constrictive pericar-
ditis showed an even greater symptom duration (average 83± 
35 days) than did those who presented with PE. These results 
demonstrate that initial echocardiographic characteristics are 
informative with respect to both disease duration and inflam-
mation severity. The fact that patients initially diagnosed with 
advanced disease are more likely to require pericardiectomy 
than patients with less severe illness emphasizes that TB peri-
carditis needs to be detected early. Timely diagnosis, followed 
by appropriate treatment, is essential to prevent constrictive 
pericarditis and pericardiectomy. We observed a beneficial ef-
fect of steroid therapy on preventing persistent pericardial con-
striction in patients with initial echogenic PE or constrictive 
physiology in the present study. However, randomized con-
trolled study will be needed to verigy this finding, because 
more patients with PE were included in the steroid therapy 
group, whereas more patients with constrictive physiology 
were in the non-steroid group.
Transient pericardial constriction
We also found that 7 patients (11.7% of the total) developed 
transient pericardial constrictions that resolved during lon-
ger follow-up (6.3±6.3 months, range 1-18 months) with use 
of anti-TB medications. Data from the Mayo Clinic showed 
that about 17% of constrictive pericarditis patients developed 
transient constrictions, the common etiology being prior car-
diovascular surgery, whereas only 1 case of TB pericarditis was 
transient.
26) However, TB pericarditis seems to be a primary 
etiology of transient constrictive pericarditis in Korea, where 
Table 4. Continued
Pericardiectomy (+) (n=10) Pericardiectomy (-) (n=50) p
Steroids
Use (%)
Initial dose (mg/day)
5 (50.0)
47±13
23 (46.0)
53±11
1.000
0.299
WBC: white blood cell, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, TB: tuberculosis, PCR: polymerase chain reaction, 
ADA: adenosine deaminase, PE: pericardial effusion
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Fig. 4. Kaplan-Meier analyses of pericardiectomy in patients with or without initial pericardial constriction (A), and in patients with echogenic 
pericardial effusion (PE) or echo-free PE (B). PE: pericardial effusion.384   Echocardiography in Tuberculous Pericarditis
Table 5. Comparisions of clinical characteristics for treatment with or without steroids in patients with echogenic pericardial effusion or con-
strictive physiology 
No steroid (n=18) Steroid (n=20) p
Age (years) 61.2±18.5 59.8±15.1 0.797
Male/Female 7/11 9/11 0.752
Weight (kg) 53.2±11.4 54.6±7.40 0.659
Height (cm) 158.3±10.90  159.6±8.600 0.683
Symptom
Number of symptoms
Symptom duration (days)
Dyspnea
Cough
Fever
Chest pain
Fatigue
Edema
Weight loss
Abdominal pain
Sweat
4.7±1.6
47.6±37.1
16 (88.9)
12 (66.7)
11 (61.1)
7 (38.9)
10 (55.6)
9 (50.0)
10 (55.6)
7 (38.9)
2 (11.1)
3.6±1.1
45.1±43.9
16 (80.0)0
13 (65.0)0
13 (65.0)0
5 (25.0)
7 (35.0)
6 (30.0)
6 (30.0)
3 (15.0)
3 (15.0)
0.021
0.859
0.663
1.000
1.000
0.489
0.328
0.320
0.188
0.144
1.000
Manifestation
Pericardial effusion
Effusive-constrictive
Constrictive
9 (50.0)
5 (27.8)
4 (22.2)
14 (70.0)0
4 (20.0)
2 (10.0)
0.663
ECG
Nonspecific ST-T change
Low voltage
Sinus tachycardia
Atrial fibrillation
Normal
11 (61.1)
12 (66.7)
7 (38.9)
3 (16.7)
0 (0.0)
10 (50.0)0
7 (35.0)
6 (30.0)
3 (15.0)
4 (20.0)
0.532
0.103
0.734
1.000
0.107
Initial laboratory data
WBC (/mm3)
ESR (mm/h)
CRP (mg/dL)
8122±6559
52±39
6.18±6.70
6520±1536
64±39
9.44±6.51
0.325
0.472
0.216
Chest X-ray
Cardiomegaly
Pulmonary edema
Pleural effusion
Pulmonary TB lesion
14 (77.8)
5 (27.8)
15 (83.3)
4 (22.2)
17 (85.0)0
0 (0.0)0
20 (100)0.
5 (25.0)
0.687
0.017
0.097
1.000
Chest CT
Pericardial calcification
Pericardial thickening
Lymphadenopathy
Lung field lesion
1 (8.3)
11 (91.7)
5 (41.7)
7 (58.3)
0 (0.0)0
12 (92.3)0
9 (69.2)
7 (53.8)
0.480
1.000
0.238
1.000
Other Tb site 
Pulmonary
Other
9 (50.0)
1 (5.6)
7 (35.0)
0 (0.0)0
0.257
Pericardial fluid analysis
Bloody
Lymphocyte-dominant
Protein (g/dL)
LDH (U/L)
Adenosine deaminase (U/L)
WBC (/mm3)
3 (37.5)
7 (87.5)
5.4±0.5
2477±1062
89.7±79.1
4115±3180
7 (43.8)
14 (93.3)0
5.2±0.7
1562±1387
112.0±57.00
09874±17825
1.000
1.000
0.501
0.147
0.444
0.381Hyung Oh Choi, et al.   385
Table 5. Continued
No steroid (n=18) Steroid (n=20) p
Diagnostic criteria
TB in pericardial fluid
TB culture-positive
TB PCR-positive
Bacilli or granuloma
TB in other sites
High ADA
Criteria count
Definite diagnosis
1 (9.1)
5 (45.5)
4 (44.4)
6 (66.7)
10 (55.6)
5 (55.6)
1.7±1.1
11 (61.1)
0 (0.0)0
3 (18.8)
7 (50.0)
13 (86.7)0
7 (35.0)
14 (87.5)0
2.2±0.8
16 (80.0)0
0.407
0.206
1.000
0.326
0.328
0.142
0.132
0.288
Anti-tuberculosis drugs
Medication duration (months)
Secondary drugs
11.3±11.3
1 (5.6)
10.5±4.90
4 (20.0)
0.766
0.344
Pericardiectomy 5 (27.8) 5 (25)0. 1.000
ECG: electrocardiogram, WBC: white blood cell, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, LDH: lactate dehydrogenase, 
TB: tuberculosis, ADA: adenosine deaminase
TB is more prevalent than in the United States.
27) The relative-
ly high incidence of transient pericardial constrictions in TB 
pericarditis patients suggests observation for 6 months with 
adequate anti-TB medication and echocardiography follow-
up, especially in patients initially presenting without overt con-
strictive pericarditis.
Study limitations
This study was a retrospective observational study, and hen-
ce has the limitations inherent to such studies. Not all pa-
tients met definitive TB PE diagnosis criteria. Steroid treat-
ment was not controlled, being at the discretion of attending 
physicians, and this may affect the incidence of pericardial 
constriction and pericardiectomy. However, neither the pro-
portions of steroid-treated patients, nor initial steroid thera-
py doses, differed between patient groups (Table 3 and 4). The 
lack of invasive catheterization data for understanding the 
hemodynamic aspects of disease evolution, particularly in 
patients with constrictive pericarditis, was another limita-
tion of this study. Constrictive physiology determined by a sig-
nificant respiratory variation in mitral inflow E wave velocity 
(≥25%) could have lead to false negative in diagnosing con-
striction, especially in patients with increased preload.
28) The 
clinical outcomes and predictors for constriction demonstrat-
ed in this study were limited to TB pericarditis. We could not 
demonstrate independent determinants of outcomes using 
multivariate regression analysis, because no variable with sta-
tistical significance was identified, probably due to relatively 
small number of patients and large number of variables. Al-
though the incidence of constrictive pericarditis in TB pericar-
ditis was higher than in other types of pericarditis such as ma-
lignant or idiopathic pericarditis,
13) further studies would be 
necessary to evaluate clinical outcomes and poor prognostic 
predictors in these specific categories.
Conclusions
In conclusion, initial echocardiographic and clinical pre-
sentations are of substantial prognostic value in patients with 
newly diagnosed TB pericarditis, and initial pericardial con-
striction and echogenic PE seem to be poor prognostic signs 
for persistent constrictive pericarditis and pericardiectomy. 
These results suggest that early TB diagnosis and prompt an-
ti-TB therapy may be critical.
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